Industry News
Cancer Survivors And Partners More Prone To Anxiety Than Depression
Jun 05, 2013
Long-term cancer survivors are not at a much higher risk of developing depression compared with healthy people, but they are more likely to experience anxiety. The finding was published today in The Lancet Oncology and outlines that not only are the survivors at risk for anxiety, but their partners face similar levels of depression and higher levels of anxiety than the survivors themselves... Read More
New Oncogene And Potential Target In Lung Cancer: RET Rearrangement
Jun 05, 2013
In results presented at ASCO 2013, a University of Colorado Cancer Center study provided important details for a recently identified driver and target in lung adenocarcinoma: rearrangement of the gene RET. The finding is an important step along a trajectory like that which led to FDA approval of the drug crizotinib, which targets a somewhat similar rearrangement in the ALK gene... Read More
Genetic Screening Declined By Many Despite Good Prognosis
Jun 05, 2013
Even if Australians with newly diagnosed bowel cancer were routinely tested for a genetic predisposition to further cancers, one in three people would still not take the necessary steps to use that information to prevent further disease... Read More
Cancer Survivors And Their Partners At Greater Risk Of Anxiety, Not Depression
Jun 05, 2013
Long-term cancer survivors are not at a much higher risk of developing depression compared with healthy people, but they are more likely to experience anxiety. The finding was published today in The Lancet Oncology and outlines that not only are the survivors at risk for anxiety, but their partners face similar levels of depression and higher levels of anxiety than the survivors themselves... Read More
Study Finds Bladder Cancer Recurrence And Mortality Could Improve With Better Treatment Compliance
Jun 05, 2013
Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr... Read More
Nivolumab Tested For Safety In Kidney Cancer
Jun 05, 2013
Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center presented a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma (mRCC) at the ASCO Annual Meeting... Read More
Treatment Decisions: Doctor's Advice For Cancer Patients
Jun 05, 2013
Patients' desire for participation changes over the course of the disease What treatment a doctor recommends for advanced cancer not only depends on medical aspects. His relationship to the individual patients and his own view of their life situation at their age play a role. This was found out by a research team led by Dr... Read More
Researchers Reveal Potential New Way To Suppress Tumor Growth
Jun 05, 2013
Researchers at the University of California, San Diego School of Medicine, with colleagues at the University of Rochester Medical Center, have identified a new mechanism that appears to suppress tumor growth, opening the possibility of developing a new class of anti-cancer drugs. Writing in this week's online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), Willis X... Read More
Hope Offered By New Treatment For Neuroblastoma
Jun 05, 2013
Researchers at Karolinska Institutet in Sweden have found a promising strategy for defeating neuroblastoma - a malignant form of cancer in children - that focuses on the so-called MYCN protein. A specific chemical molecule helps to break down MYCN, which either kills the cancer cell or makes it mature into a harmless neuron... Read More
Genetic Testing Could Protect Younger African Americans With Breast Cancer And Their Relatives
Jun 05, 2013
A high percentage of African-American women with breast cancer who were evaluated at a university cancer-risk clinic were found to carry inherited genetic mutations that increase their risk for breast cancer... Read More
Previous Page Next Page